Christopher G. White - Oct 1, 2021 Form 3 Insider Report for OCULAR THERAPEUTIX, INC (OCUL)

Role
Chief Business Officer
Signature
/s/ Donald Notman, Attorney-in-Fact for Christopher G. White
Stock symbol
OCUL
Transactions as of
Oct 1, 2021
Transactions value $
$0
Form type
3
Date filed
10/8/2021, 04:33 PM
Next filing
Feb 7, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OCUL Stock Option (right to buy) Oct 1, 2021 Common Stock 38.8K $5.13 Direct F1
holding OCUL Stock Option (right to buy) Oct 1, 2021 Common Stock 73.3K $4.39 Direct F2
holding OCUL Stock Option (right to buy) Oct 1, 2021 Common Stock 154K $18.31 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person was granted an option to purchase 60,000 shares on July 9, 2019, vesting over four years, with 1/4 of the shares underlying the option vesting on July 9, 2020, and 1/48 of the shares underlying the option vesting monthly thereafter. Prior to becoming subject to Section 16, the reporting person partially exercised this option to purchase 21,249 shares and sold the shares of common stock received upon such exercise in open market sales.
F2 The reporting person was granted an option to purchase 92,600 shares on January 30, 2020, vesting over four years, with 1/48 of the shares underlying the option vesting monthly beginning on the one-month anniversary of the date of grant. Prior to becoming subject to Section 16, the reporting person partially exercised this option to purchase 19,291 shares and sold the shares of common stock received upon such exercise in open market sales.
F3 The option was granted on February 17, 2021, vesting over four years, with 1/48 of the shares underlying the option vesting monthly beginning on the one-month anniversary of the date of grant.

Remarks:

Exhibit List Exhibit 24 - Power of Attorney